Member Publications - July 2015

  1. Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial. Moss RB, Flume PA, Elborn JS, Cooke J, Rowe SM, McColley SA, Rubenstein RC, Higgins M; VX11-770-110 (KONDUCT) Study Group. Lancet Respir Med. 2015 Jul;3(7):524-33. doi: 10.1016/S2213-2600(15)00201-5.

  2. Molecular epidemiology of Aspergillus collected from cystic fibrosis patients. Sabino R, Ferreira JA, Moss RB, Valente J, Veríssimo C, Carolino E, Clemons KV, Everson C, Banaei N, Penner J, Stevens DA. J Cyst Fibros. 2015 Jul;14(4):474-81. doi: 10.1016/j.jcf.2014.10.005.